ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Mountain Crest Acquisition Corporation II

Mountain Crest Acquisition Corporation II (MCAD)

10.43
0.00
(0.00%)
Closed November 23 3:00PM
0.00
0.00
(0.00%)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
10.43
Bid
10.30
Ask
10.42
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
10.43
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

MCAD Latest News

Better Therapeutics Closes Business Combination and Debuts on Nasdaq

Trading to commence on Nasdaq on Oct. 29, 2021, under the ticker symbol BTTX Better Therapeutics, Inc., a prescription digital therapeutics (PDT) company delivering cognitive behavioral therapy...

Mountain Crest Acquisition Corp. II Stockholders Approve Business Combination with Better Therapeutics Inc.

NEW YORK, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. II (NASDAQ: MCAD) (the “Company”), a publicly traded special purpose acquisition company, announced today that in a...

Mountain Crest Acquisition Corp. II and Better Therapeutics, Inc. Announce Registration Statement Effectiveness and Scheduled Special Meeting to Approve Business Combination on October 27, 2021

NEW YORK and SAN FRANCISCO, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. II (NASDAQ: MCAD, “Mountain Crest II”), a publicly-traded special purpose acquisition company and...

Better Therapeutics to Participate in Lake Street’s 5th Annual Best Ideas Growth (BIG5) Conference on September 14-15, 2021

Better Therapeutics, Inc. (“Better Therapeutics”), a prescription digital therapeutics (PDT) company developing cognitive behavioral therapy to address root causes of cardiometabolic diseases...

Better Therapeutics Highlights Recent Progress and Updates Outlook Through 2022

Pivotal trial of BT-001 in type 2 diabetes expected to be fully enrolled in Q4 2021, with primary endpoint readout in Q1 2022; de novo submission to FDA requesting marketing authorization planned...

Better Therapeutics Expands Real-World Evidence Study Initiative With Addition of Catalyst Health Network

Open-label, real-world study will evaluate BT-001’s cognitive behavioral therapy approach to change behaviors at the root cause of type 2 diabetes Study to evaluate the durability of treatment...

Better Therapeutics Launches Real World Evidence Study of Prescription Digital Therapeutic for Type 2 Diabetes

Open-label, non-randomized, controlled study will span one year and evaluate BT-001’s cognitive behavioral therapy approach to change behaviors at root cause of type 2 diabetes Study to evaluate...

Better Therapeutics to Become Publicly Traded Prescription Digital Therapeutics Company via Merger with Mountain Crest Acquis...

Transaction values Better Therapeutics at a pro forma fully diluted enterprise value of approximately $187 million with existing Better Therapeutics shareholders rolling over 100% of their equity...

Mountain Crest Acquisition Corp. II Announces that Common Stock and Rights to Commence Separate Trading on or about March 17,...

New York, N.Y., March 15, 2021 (GLOBE NEWSWIRE) -- March 15, 2021 Mountain Crest Acquisition Corp. II (the “Company”) (NASDAQ: MCADU), a blank check company formed for the purpose of entering...

Mountain Crest Acquisition Corp. II Announces Closing of Fully-Exercised Over-Allotment Option in Connection with Its Initial...

New York, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. II (NASDAQ: MCADU, the “Company”) announced today that the underwriters in its initial public offering, pursuant to...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PDYNPalladyne AI Corporation
US$ 4.59
(129.50%)
83.07M
QMCOQuantum Corporation
US$ 9.11
(126.62%)
39.48M
NANano Labs Ltd
US$ 8.26
(89.02%)
2.03M
XCURExicure Inc
US$ 18.60
(71.27%)
4.59M
SKKSKK Holdings Limited
US$ 1.75
(59.09%)
107.47M
AMIXAutonomix Medical Inc
US$ 6.21
(-54.07%)
946.09k
CETXCemtrex Inc
US$ 0.1146
(-41.74%)
24.39M
MSWMing Shing Group Holdings Ltd
 5.90
(-35.52%)
417.08k
RMSGReal Messenger Corporation
US$ 3.09
(-26.25%)
313.51k
ENSCEnsysce Biosciences Inc
US$ 0.4414
(-25.49%)
4M
ELABElevai Labs Inc
US$ 0.0201
(-0.50%)
415.87M
NVDANVIDIA Corporation
US$ 141.95
(-3.22%)
229.93M
SMCISuper Micro Computer Inc
US$ 33.15
(11.62%)
155.43M
VRPXVirpax Pharmaceuticals Inc
US$ 0.5501
(-6.72%)
154.17M
SOUNSoundHound AI Inc
US$ 8.24
(18.05%)
103.6M

Discussion

View Full Feed
janice shell janice shell 5 minutes ago
Ahhhh, I see. That's the VinoLok described in the blog I posted.

BUT... the wines they say they use it for are Piemontese wines that DO need to be aged, so I wonder how that works.
moola26 moola26 6 minutes ago
The only ones lost here are the paid posters wanting shareholders to give up theirs shares for 6 years with no results.
Yikes! Sorry you all wasted your time. Shareholders are golden

MAJORITY HOLDING STRONG$$$$
WooptdooU WooptdooU 6 minutes ago
The baldheaded (his word) GRIFTER(my word) NEEDS to return the CASH...eom
LWLG
TRUISM TRUISM 6 minutes ago
+++THE BAGWORM GENOME REVEALS A UNIQUE FIBROIN GENE THAT PROVIDES HIGH TENSILE STRENGTH+++
APRIL 29, 2019
https://www.nature.com/articles/s42003-019-0412-8 LINK


MECHANICAL PROPERTIES OF SILKS


The repetitive motif in bagworm fibroin c
KBLB
Louie_Louie Louie_Louie 6 minutes ago
Anyone know what's happened with Tim Howard? You'd think he'd be all over this since Trump won, but no one has posted a single thing from him that's current in a long time. Anyone still following his blog?
FMCC
Magician19 Magician19 8 minutes ago
Yes...based on Nov. 2024 Quarterly report. He is still CEO
ICTY
delerious1 delerious1 8 minutes ago
There is absolutely no reason that we can't have more than 1 coin in our portfolio...no one knows which one will be the star, or even if it will be only 1....that's why I have a small basket of 5 or 6 coins....all you need is for 1 to pop
XRPUSD
arizona1 arizona1 9 minutes ago
Huge LOL! Now you're just figuring it out assholes? I can't wait to see those concentration camps filled with illegal workers separated from their American kids. #FAFO

Trump's deportation vow alarms Texas construction industry

Clear signals President-elect Donald T
Hoskuld Hoskuld 10 minutes ago
Again Hosai, this is clearly not your field of expertise. There is a standard path to approval and Anavex has not done the standard and expected things necessary to guarantee approval. It is counting on a hail mary pass - it is counting on regulatory agencies (starting with the EMA) to make a few
AVXL
WooptdooU WooptdooU 10 minutes ago
Scope, you seem to ignore WHAT HAPPENED and CONTINUES to happen for their CAREER GRIFT.

GRIFTER lil lebby (and his sf Grift family) and the marciNOBODI guy TOOK $MILLIONS$ in CASH. A pure SCUM BELLY MOVE that shines of SELF DEALING...They Can Potentially fall into PERSONAL LIABILITY.
MILLIONS
aheadofthecurve aheadofthecurve 10 minutes ago
Weird article...https://www.defenseworld.net/2024/11/23/respirerx-pharmaceuticals-otcmktsrspi-versus-syros-pharmaceuticals-nasdaqsyrs-head-to-head-survey.html
RSPI
S-BEES-BUMBLEBEE S-BEES-BUMBLEBEE 10 minutes ago
$LGHL @.1941 >>> O/S currently only at 6.87m as of DT!

Ultralowfloater AI/BTC/META_WLI/Broker/CFD/CarbonF./Crypto-play! PT: $10+/Sh.! DYOR. *NFA

Also Operating Cash Flow Positive per DT! Looky, looky here yourselves...

Link: https://dilutiontracker.com
LGHL
againstallodds againstallodds 11 minutes ago
No tangible sign of ANY improvement

ONLY REAL GOLD DELIVERY CREATES VALUE. !!!
NBRI
trip01fun trip01fun 12 minutes ago
13 fkn posts mod 1/2 of those were all ecmh
ECMH
Hoskuld Hoskuld 13 minutes ago
Pricing is the US is pretty sweet - ROW not so much. If bicyclical then the motion will be elliptical.
VRNA
Hoskuld Hoskuld 14 minutes ago
BakedLangostino, I think your thinking on this is not correct. It is not kind to mismanage a trial so that Rett patients won't have access to an effective treatment. That is what happened. And, no, failing to spend the money was a huge fail.

The old saw you mention - posted in tr
AVXL
dstock07734 dstock07734 14 minutes ago
Horse,

LP is playing multidimensional chess and quite possibly at a grandmaster level !!!

I couldn't agree with you more.
NWBO
gp22 gp22 14 minutes ago
$GFAI @ $1.30: AI Robotics. Micro-floater trading below cash. Well regarded. $PDYN was @ $1.40s on Thursday...Load up $GFAI
GFAI PDYN
IH Admin [Shelly] IH Admin [Shelly] 15 minutes ago
I think they were all glass - they looked much like the picture in the article I made in the edit.
gp22 gp22 15 minutes ago
$GFAI @ $1.30: AI Robotics. Micro-floater trading below cash. Well regarded. $PDYN was @ $1.40s on Thursday...Load up $GFAI
GFAI PDYN
janice shell janice shell 18 minutes ago
It's done quite a bit. Most of them at least go to the trouble to buy a property in the place they're running in. Or maybe rent.
delerious1 delerious1 18 minutes ago
😎The company is doing it right and the shareprice reflects that...things are goin' great and they're only gettin' better.... mining's all right gettin' good grades.

The future's so bright I gotta wear shades 😎
NBRI

Your Recent History

Delayed Upgrade Clock